Abstract:Background: The optimal biomarkers for early diagnosis, treatment, and prognosis of tuberous sclerosis complex (TSC)-associated epilepsy are not yet clear. This study identifies the crucial genes involved in the pathophysiology of TSC-associated epilepsy via a bioinformatics analysis. These genes may serve as novel therapeutic targets. Methods: Gene chip data sets (GSE62019 and GSE16969) comprising the data of patients with TSC-associated epilepsy and healthy control participants were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) in the GEO database were identified using the GEO2R gene expression analysis tool. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, Gene Ontology function, and protein-protein interaction (PPI) network analyses were then conducted. The results were analyzed using R language, and are presented in volcano plots, Venn diagrams, heatmaps, and enrichment pathway bubble charts. A gene set enrichment analysis (GSEA), was conducted to examine the KEGG pathways and crucial genes linked to TSC-associated epilepsy. The potential genes were compared with the genes listed in the Online Mendelian Inheritance in Man (OMIM) database and analyzed against the literature to determine their clinical significance. Finally, the expression of the key genes in the TSC-associated epilepsy mice cerebral cortex was examined through immunohistochemical staining. Results: The intersection of the GSE62019 and GSE16969 data sets revealed 151 commonly upregulated DEGs. The KEGG enrichment analysis indicated that these DEGs affected the occurrence and development of TSC-associated epilepsy by modulating complement and coagulation cascades, glycosaminoglycans in cancer, and extracellular matrix-receptor interactions. Four high-scoring clusters emerged, and podoplanin (PDPN) was identified as a key gene through the construction of a PPI network of the common DEGs using the Cytoscape software. A GSEA of the DEGs revealed that the common DEG PDPN was enriched in both data sets in pathways related to platelet activation, aggregation, and the glycoprotein VI (GPVI)-mediated activation cascade. Immunohistochemical staining revealed a significant elevation in PDPN expression in the cerebral cortex of mice with TSC-associated epilepsy. Conversely, the control group mice did not display any significantly positive neurons. Conclusions: The discovery of these crucial genes and signaling pathways extends understanding of the molecular processes underlying the development of TSC-associated epilepsy. Additionally, our findings may provide a theoretical basis for research into targeted clinical treatments.

Research progress of dishevelled, Egl-10,and pleckstrin domain-containing protein 5 gene-related epilepsy

Mapping The Spatio-Temporal Pattern Of The Mammalian Target Of Rapamycin (Mtor) Activation In Temporal Lobe Epilepsy

[Research Advances in the Role of Mtor Signaling Pathway in Autism Spectrum Disorder].

De Novo Mutation in DEPDC5 Associated with Unilateral Pachygyria and Intractable Epilepsy

Role of the Mtor Signaling Pathway in Epilepsy

Phosphatidylinositol 3-Kinase/protein Kinase B/mammalian Target of Rapamycin Signaling Pathway and Epilepsy

Advances in the mTOR signaling pathway and its inhibitor rapamycin in epilepsy

DEPDC5 Variants Associated Malformations of Cortical Development and Focal Epilepsy With Febrile Seizure Plus/Febrile Seizures: The Role of Molecular Sub-Regional Effect

Modeling mTORopathy-related epilepsy in cultured murine hippocampal neurons using the multi-electrode array

Identification of Genetic Characteristics in Pediatric Epilepsy with Focal Cortical Dysplasia Type 2 Using Deep Whole-Exome Sequencing

More is Different in mTORopathies

DEPDC5 plays a vital role in epilepsy: Genotypic and phenotypic features in cohort and literature

PPP3CA gene-related developmental and epileptic encephalopathy: Expanding the electro-clinical phenotype

[Genotype and Phenotype of Children with DEPDC5 Gene Variants Related Epilepsy].

Mechanistic target of rapamycin (mTOR) signaling in status epilepticus

Abnormal increased mTOR signaling regulates seizure threshold in Dravet syndrome

Epg5 links proteotoxic stress due to defective autophagic clearance and epileptogenesis in Drosophila and Vici syndrome patients

Recent Progress in Identifying Genetic and Epigenetic Contributions to Epilepsy

Screening for biomarkers of tuberous sclerosis complex-associated epilepsy: a bioinformatics analysis

The landscape of epilepsy-related GATOR1 variants